Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 11
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP21F1001 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $407.24K | 2020-12-07 | 2020-12-15 | 325412 | 8507846174!ADENOVIRUS TYPE 4 A |
| SPE2DP20F6215 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $407.24K | 2020-07-22 | 2020-07-28 | 325412 | 8507538018!ADENOVIRUS TYPE 4 A |
| SPE2DP20F6214 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $407.24K | 2020-07-22 | 2020-07-28 | 325412 | 8507538017!ADENOVIRUS TYPE 4 A |
| SPE2DP20F3408 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $407.24K | 2020-03-13 | 2020-03-24 | 325412 | 8507242534!ADENOVIRUS TYPE 4 A |
| SPE2DP26F5472 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $343.53K | 2026-05-11 | 2026-05-19 | 325412 | 8512097415!ADENOVIRUS TYPE 4 A |
| SPE2DP26F5468 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $343.53K | 2026-05-11 | 2026-05-19 | 325412 | 8512097273!ADENOVIRUS TYPE 4 A |
| SPE2DP26F5467 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $343.53K | 2026-05-11 | 2026-05-19 | 325412 | 8512097271!ADENOVIRUS TYPE 4 A |
| SPE2DP26F4638 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $343.53K | 2026-04-15 | 2026-04-29 | 325412 | 8512042009!ADENOVIRUS TYPE 4 A |
| SPE2DP26F4635 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $343.53K | 2026-04-15 | 2026-04-29 | 325412 | 8512042003!ADENOVIRUS TYPE 4 A |
| SPE2DP26F4634 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $343.53K | 2026-04-15 | 2026-04-29 | 325412 | 8512042000!ADENOVIRUS TYPE 4 A |
| SPE2DP26F3587 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $343.53K | 2026-03-18 | 2026-03-25 | 325412 | 8511984336!ADENOVIRUS TYPE 4 A |
| SPE2DP26F0985 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-12-01 | 2025-12-09 | 325412 | 8511784115!ADENOVIRUS TYPE 4 A |
| SPE2DP26F0984 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-12-01 | 2025-12-09 | 325412 | 8511784113!ADENOVIRUS TYPE 4 A |
| SPE2DP25F109U | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-09-08 | 2025-09-23 | 325412 | 8511624197!ADENOVIRUS TYPE 4 A |
| SPE2DP25F054T | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-08-12 | 2025-08-26 | 325412 | 8511565394!ADENOVIRUS TYPE 4 A |
| SPE2DP25F9621 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-07-14 | 2025-07-29 | 325412 | 8511499275!ADENOVIRUS TYPE 4 A |
| SPE2DP25F9619 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-07-14 | 2025-07-29 | 325412 | 8511499273!ADENOVIRUS TYPE 4 A |
| SPE2DP25F8220 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-06-16 | 2025-06-24 | 325412 | 8511446737!ADENOVIRUS TYPE 4 A |
| SPE2DP25F8217 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-06-16 | 2025-06-24 | 325412 | 8511446668!ADENOVIRUS TYPE 4 A |
| SPE2DP25F8214 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-06-16 | 2025-06-24 | 325412 | 8511446665!ADENOVIRUS TYPE 4 A |
| SPE2DP25F6738 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-05-12 | 2025-05-20 | 325412 | 8511369399!ADENOVIRUS TYPE 4 A |
| SPE2DP25F5527 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-04-07 | 2025-04-29 | 325412 | 8511296302!ADENOVIRUS TYPE 4 A |
| SPE2DP25F5525 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-04-07 | 2025-04-29 | 325412 | 8511296201!ADENOVIRUS TYPE 4 A |
| SPE2DP25F4435 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-03-06 | 2025-03-25 | 325412 | 8511229451!ADENOVIRUS TYPE 4 A |
| SPE2DP25F4433 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $330.31K | 2025-03-06 | 2025-03-25 | 325412 | 8511229349!ADENOVIRUS TYPE 4 A |